Turn emails into revenue with Brew. No credit card, free credits to try.
ro.co · newsletter
Explore this email design and adapt it to your own brand. Review the copy, links, and offer before sending.
Ro.Co Icon
FDA-approved GLP-1s, 100% online (if eligible)
What real Ro members pay for GLP-1s | Get started
Thousands of people are saving on FDA-approved GLP-1s on Ro. | Get started
See how much you can save on Ro | Get started
Important Safety Information Rx only. Wegovy (semaglutide) and Zepbound (tirzepatide) are prescription medications for weight management, paired with diet and exercise. Ozempic (semaglutide) injection is a prescription medication used along with diet and exercise to treat type 2 diabetes. It may be prescribed off-label for weight management at a provider's discretion. All three medications may cause serious side effects including possible thyroid tumors and thyroid cancer. Do not use them if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). They may also cause other serious side effects, including pancreatitis, gallbladder problems, increased risk of low blood sugar, kidney problems, serious stomach problems and allergic reactions, changes in vision in patients with type 2 diabetes, and increased heart rate. Tell your provider if you have a planned surgery. For more complete information, including Boxed Warning, ro.co/safety
Wegovy®, Ozempic®, and Novo Nordisk® are registered trademarks of Novo Nordisk A/S.
Zepbound®, Zepbound® KwikPen®, and Lilly® are registered trademarks of Eli Lilly and Company.
Ro promotional content is independent from the manufacturer.
Sexual health
Weight loss
Fertility
Hair loss
Skin care
Daily health
© 2026 Roman Health Ventures,
625 Avenue of the Americas, NY, NY 10011
Contact us
This email was sent to you because you indicated that you'd like to receive marketing and promotional emails from Ro. This email is intended for the recipient only.
Privacy Policy Terms of Service
No longer want to receive these emails?
Unsubscribe
Browse more email designs